Dr.Catherine Bollard, Washington Children’s Hospital, Washington, DC Dr. Daniel Powell, University of Pennsylvania, Philadelphia, PA Immunotherapy Some of the most exciting results in cancer medicine, in the last decade, have come about by treating relapsed patients with B cell lymphoma with their own T cells that have been modified to attack the tumor cells.
2014 – Invasion and Metastasis November 6 – 9th, 2014 Ann Chambers, PhD, University of Western Ontario, London, ON Canada Zena Werb, PhD, University of California, San Francisco, CA Most cancer deaths are due to metastasis – the spread of cancer from its site of origin to distant, vital organs, and the physiological
CHAIRMEN Joan Brugge, Harvard Medical School, Boston MA Jeffrey Engelman, Massachusetts General Hospital, Boston, MA PARTICIPANTS Alberto Bardelli, PhD, University of Torino, Candiolo, Italy Jose Baselgaj, Memorial Sloan-Kettering Cancer Institute, New York, NY Bruce A. Chabner, MD, Massachusetts General Hospital, Boston, MA Dr. William Dalton, Moffitt Caner Center & Research Institute, Tampa, FL Jeffrey Engelman,
January 30, 2012 The William Guy Forbeck Research Foundation: Annual Forum 2012 – Summary Tumor Metabolism Co-Chairs: Lewis C. Cantley, PhD., Beth Israel Deaconess Medical Center, Boston, MA and Eileen White, PhD., The Cancer Institute of New Jersey, New Brunswick, NJ. Participants: John Blenis, PhD., Harvard Medical School, Boston, MA; Heather Christofk, PhD, UCLA, Los
The William Guy Forbeck Research Foundation: Annual Forum 2011 – Summary Epigenetics & Drug Therapy Co-Chairs: Scott A. Armstrong, MD, Ph.D., Dana Farber Cancer Institute, Boston, MA Steven Henrikoff, Ph.D., Fred Hutchinson Cancer Research Center, Seattle, WA Participants Bruno Amati, Ph.D., Istituto Italiano di Tecnologia (IIT) at the IFOM-IEO Campus Center for Genomic Science of